Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUNLUN ENERGY
00135
5
CHINA OILFIELD
02883
HK Stock MarketDetailed Quotes
CHUNLI MEDICAL (01858)
- 9.960
- 0.0000.00%
Market Closed May 21 16:02 CST
3.82BMarket Cap12.22P/E (TTM)
10.230High9.890Low667.75KVolume9.970Open9.960Prev Close6.70MTurnover0.70%Turnover Ratio12.66P/E (Static)383.57MShares20.59052wk High1.11P/B947.60MFloat Cap9.77652wk Low0.28Dividend TTM95.14MShs Float61.733Historical High0.145Dividend LFY3.41%Range %-0.005Historical Low10.031Avg Price250Lot Size2.85%Div Yield TTM1.46%Div Yield LFY
CHUNLI MEDICAL (01858) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 118.69%272.63M | ---- | 44.98%114.48M | ---- | -55.13%124.66M | ---- | -37.33%78.96M | ---- | -9.72%277.82M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | 42.49%-6.32M | ---- | 47.13%-3.22M | ---- | 8.59%-10.98M | ---- | 39.56%-6.08M | ---- | -78.01%-12.01M |
| Impairment and provisions: | ---- | 23.65%46.94M | ---- | 256.79%39.33M | ---- | 51.72%37.96M | ---- | -7.86%11.02M | ---- | -17.33%25.02M |
| -Other impairments and provisions | ---- | 23.65%46.94M | ---- | 256.79%39.33M | ---- | 51.72%37.96M | ---- | -7.86%11.02M | ---- | -17.33%25.02M |
| Revaluation surplus: | ---- | 7.34%-8.74M | ---- | 8.01%-4.3M | ---- | 1.83%-9.43M | ---- | -6.57%-4.67M | ---- | -1.27%-9.61M |
| -Other fair value changes | ---- | 7.34%-8.74M | ---- | 8.01%-4.3M | ---- | 1.83%-9.43M | ---- | -6.57%-4.67M | ---- | -1.27%-9.61M |
| Asset sale loss (gain): | ---- | 90.19%-3.85K | ---- | 90.19%-3.85K | ---- | -904.29%-39.21K | ---- | ---39.21K | ---- | 84.57%-3.9K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 90.19%-3.85K | ---- | 90.19%-3.85K | ---- | -904.29%-39.21K | ---- | ---39.21K | ---- | 84.57%-3.9K |
| Depreciation and amortization: | ---- | 10.95%41.8M | ---- | 7.30%20.01M | ---- | 8.72%37.68M | ---- | 15.30%18.65M | ---- | 14.90%34.66M |
| -Amortization of intangible assets | ---- | 14.56%12.5M | ---- | 18.88%6.38M | ---- | 1.21%10.91M | ---- | 15.89%5.36M | ---- | 38.14%10.78M |
| Financial expense | ---- | 109.90%213.99K | ---- | 122.93%287.99K | ---- | -2,499.94%-2.16M | ---- | -97.99%-1.26M | ---- | 100.60%90.11K |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 83.68%-22.32M | ---- | 57.61%-38.64M | ---- | 29.24%-136.77M | ---- | 29.17%-91.14M | ---- | -70.22%-193.31M |
| Accounts receivable (increase)decrease | ---- | 90.52%120.41M | ---- | 643.52%87.73M | ---- | -78.56%63.2M | ---- | -51.70%11.8M | ---- | 171.54%294.85M |
| Accounts payable increase (decrease) | ---- | 65.77%-37.29M | ---- | 20.66%-70.92M | ---- | -214.95%-108.91M | ---- | -17.12%-89.39M | ---- | -58.85%94.75M |
| Special items of business | 85.50%-10.93M | -185.81%-2.49M | 1,110.26%174.57M | -206.41%-3.28M | 41.87%-75.34M | 638.01%2.9M | -225.68%-17.28M | 20.60%3.09M | -7.83%-129.61M | -33.83%-539.07K |
| Net cash from operations | 85.50%-10.93M | 21,412.40%404.84M | 1,110.26%174.57M | 304.88%141.49M | 41.87%-75.34M | -100.37%-1.9M | -225.68%-17.28M | -77.20%-69.06M | -7.83%-129.61M | 1,147.85%511.71M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | -24.36%15.61M | -48.91%6.62M | -42.22%6.62M | 20.54%6.62M | -7.74%20.64M | -5.80%12.96M | -16.35%11.46M | -11.16%5.49M | 65.56%22.37M |
| Sale of fixed assets | ---- | 9.52%23K | -74.18%23K | 9.52%23K | ---- | 244.11%21K | --89.09K | --21K | --437.73K | -90.39%6.1K |
| Purchase of fixed assets | -9.20%-19.99M | -20.25%-59.13M | -50.52%-48.49M | -37.88%-30.12M | -35.62%-18.31M | -47.92%-49.17M | 6.88%-32.22M | -14.11%-21.84M | -1,215.97%-13.5M | -33.48%-33.24M |
| Acquisition of subsidiaries | ---- | -33.33%-2.2M | ---2.2M | ---2.2M | ---- | 76.39%-1.65M | ---- | ---- | ---- | ---6.99M |
| Recovery of cash from investments | ---- | -27.51%1.69B | -52.61%744M | -47.23%744M | -10.50%744M | -0.65%2.33B | 2.93%1.57B | -7.49%1.41B | 8.67%831.3M | 66.57%2.35B |
| Cash on investment | ---- | 21.79%-1.76B | 41.33%-880M | 34.85%-860M | ---- | 6.85%-2.24B | 5.00%-1.5B | 16.40%-1.32B | 2.50%-740M | -10.86%-2.41B |
| Net cash from investment operations | -102.73%-19.99M | -300.04%-111.7M | -454.23%-180.05M | -277.90%-141.67M | 774.63%732.31M | 168.46%55.84M | 162.34%50.83M | 224.56%79.64M | 5,297.49%83.73M | 89.31%-81.56M |
| Net cash before financing | -104.71%-30.92M | 443.50%293.14M | -116.34%-5.48M | -101.78%-188.2K | 1,531.76%656.97M | -87.46%53.94M | 149.49%33.55M | 110.28%10.58M | 61.33%-45.89M | 159.61%430.16M |
| Cash flow from financing activities | ||||||||||
| Dividends paid - financing | ---80.25M | 89.02%-18.73M | 86.50%-18.73M | ---- | ---- | -42.04%-170.53M | -15.59%-138.77M | ---- | ---- | -140.32%-120.06M |
| Other items of the financing business | -3,131.17%-1.16M | 14.43%-10.79M | -54.90%-8.66M | -1,454.64%-8.62M | ---35.88K | -887.05%-12.61M | -673.26%-5.59M | -318.43%-554.4K | ---- | 85.93%-1.28M |
| Net cash from financing operations | -226,811.18%-81.41M | 83.88%-29.51M | 81.03%-27.38M | -1,454.64%-8.62M | ---35.88K | -50.94%-183.14M | -19.52%-144.36M | -318.43%-554.4K | ---- | -105.53%-121.33M |
| Effect of rate | -468.52%-320.76K | -107.92%-174.84K | -14,929.43%-248.76K | -121.49%-275.7K | 2,165.83%87.04K | 52,493.26%2.21M | -99.75%1.68K | 90.45%1.28M | ---4.21K | -100.31%-4.21K |
| Net Cash | -117.10%-112.33M | 304.04%263.63M | 70.34%-32.87M | -187.87%-8.81M | 1,531.69%656.93M | -141.84%-129.2M | 41.24%-110.81M | 109.73%10.02M | 61.39%-45.89M | 139.56%308.82M |
| Begining period cash | 23.13%1.4B | -10.03%1.14B | -10.03%1.14B | -10.03%1.14B | -10.03%1.14B | 32.26%1.27B | 32.26%1.27B | 32.26%1.27B | 32.26%1.27B | -44.88%957.19M |
| Cash at the end | -28.19%1.29B | 23.13%1.4B | -4.27%1.11B | -11.54%1.13B | 47.20%1.8B | -10.03%1.14B | 50.16%1.16B | 49.42%1.28B | 45.54%1.22B | 32.26%1.27B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"